FDA Inspection 1167967 — Beigene USA, Inc.
The FDA completed an inspection of Beigene USA, Inc. on Apr 8, 2022 in San Mateo, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 8, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Mateo, CA (United States)
Additional details
Sponsor, Contract Research Organization